Evidence map›Paper›PMID 29783898›Full record

ArticleJournal of diabetes science and technology2018

A Real-World Setting Study: Which Glucose Meter Could Be the Best for POCT Use? An Easy and Applicable Protocol During the Hospital Routine.

Alessio Mancini, Giampaolo Esposto, Silvana Manfrini, Silvia Rilli, Gessica Tinti, Giuseppe Carta, Laura Petrolati, Matteo Vidali, Simone Barocci

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessio Mancini1 School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.ORCID 0000-0002-4388-3769
Giampaolo Esposto3 Scuola di Specializzazione in Microbiologia e Virologia, Università degli Studi di Pisa, Lungarno Pacinotti, Pisa, Italy.
Silvana Manfrini4 Diabetology and Clinical Nutrition, Via Cellini, Senigallia, Italy.
Silvia Rilli4 Diabetology and Clinical Nutrition, Via Cellini, Senigallia, Italy.
Gessica Tinti4 Diabetology and Clinical Nutrition, Via Cellini, Senigallia, Italy.
Giuseppe Carta2 ASUR MARCHE AV2, O.U. Clinical Pathology, Via Cellini, 1, Senigallia (AN), Italy.
Laura Petrolati2 ASUR MARCHE AV2, O.U. Clinical Pathology, Via Cellini, 1, Senigallia (AN), Italy.
Matteo Vidali5 Servizio di Immunoematologia e Medicina Trasfusionale, Ospedale SS. Trinità, Borgomanero, Italy.
Simone Barocci2 ASUR MARCHE AV2, O.U. Clinical Pathology, Via Cellini, 1, Senigallia (AN), Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this retrospective study is to evaluate the reliability and robustness of six glucose meters for point-of-care testing in our wards using a brand-new protocol. During a 30-days study period a total of 50 diabetes patients were subjected to venous blood sampling and glucose meter blood analysis. The results of six glucose meters were compared with our laboratory reference assay. GlucoMen Plus (Menarini) with the 82% of acceptable results was the most robust glucose meter. Even if the Passing-Bablok analysis demonstrates the presence of constant systematic errors and the Bland-Altman test highlighted a possible overestimation, the surveillance error grid analysis showed that this glucose meter can be used safely. We proved that portable glucose meters are not always reliable in routinely clinical settings.

Indexed as

AdultAgedBlood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusFemaleHumansMaleMiddle AgedPoint-of-Care SystemsPoint-of-Care TestingReproducibility of ResultsRetrospective StudiesBlood GlucoseBland-Altmanblood glucosediabetesglycemic controlPassing-Bablokself-monitoring

Identifiers

PMID29783898
PMCPMC6134620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.